Audits - Gastrointestinal

Please select from the following Audits.

Mesalazine drug choice review

Mesalazine is an aminosalicylate that is used routinely to induce and maintain remission in chronic inflammatory bowel disease – ulcerative colitis and Crohn’s disease. Asacol and Octasa are also licensed for the maintenance of remission in Crohn’s ileo-colitis. The maximum dose for the 400mg preparations is 2.4g daily. Asacol MR, Ipocol and Octasa MR are all similar in terms of formulation, all enteric coated with Eudragit S, optimal pH for drug release and site of release. Although Octasa MR has not been compared to Asacol 400mg MR in a clinical trial there is in vitro evidence that the products are comparable as Octasa MR has a virtually identical in vitro dissolution to Asacol MR.

Mesalazine drug choice reviewDownload File
(Mesalazine drug choice review.pdf)

Date Uploaded: 05/12/2012

Home / Audits

Laxative Use Audit

Laxative Use AuditDownload File
(Laxative Audit August 2012 final.pdf)

Date Uploaded: 17/09/2012

Home / Audits

H2-Antagonists Formulary Adherence

This audit aims to improve adherence to the H2-antagonists recommended in the local formulary.

H2-Antagonists Formulary AdherenceDownload File
(H2Antagonist Review Aug 2011.pdf)

Date Uploaded: 17/08/2011

Home / Audits

Scheriproct switch

Both Scheriproct and Proctosedyl ointment/suppositories are compound corticosteroid-containing preparations indicated for the short-term treatment of haemorrhoids and pruritis ani. They contain the same local anaesthetic cinchocaine but differ in the steroid used, savings could be achieved across NHS Dumfries and Galloway if a switch from Proctosedyl to Scheriproct was carried out.

Scheriproct switchDownload File
(Scheriproct audit.pdf)

Date Uploaded: 27/05/2010

Home / Audits

Esomeprazole prescribing review

In 2007/08, £156,000 was spent on esomeprazole in D&G at a cost of £0.85 per DDD compared to an average £0.18 per DDD for the formulary choices omeprazole and lansoprazole. Such expenditure is not cost effective as esomeprazole is comparable to double strength omeprazole at more than “quadruple” the cost with no clinical benefit.

The objective of this audit is to ensure the appropriate prescribing of Proton Pump Inhibitors in Dumfries and Galloway.

Esomeprazole prescribing reviewDownload File
(Esomeprazole review switch audit.pdf)

Date Uploaded: 17/02/2009

Home / Audits

Alginate Formulary Adherence

This audit aims to improve formulary adherence to the alginate of choice in Dumfries and Galloway.

Alginate Formulary AdherenceDownload File
(Microsoft Word - AlginatesFormularyAdherenceAudit April 2008.pdf)

Date Uploaded: 11/04/2008

Home / Audits

PPI Review

Dyspepsia refers to a broad range of symptoms related to dysfunction of the upper gastrointestinal (GI) tract from the oesophagus to the duodenum, including retrosternal or epigastric pain, fullness, bloating, wind, heartburn, nausea and vomiting.

PPI ReviewDownload File
(Microsoft Word - Proton Pump Inhibitor prescribing review April 2008.pdf)

Date Uploaded: 11/04/2008

Home / Audits

Home | About | Glossary | Web Links | Local Links | Site Map | Disclaimer | Contact

© Primary Care Development | Crichton Hall | Bankend Road | Dumfries | Dumfries & Galloway | Scotland | DG1 4TG

Valid CSS!Valid HTML 4.01 Transitional

Website design, hosting and maintenance by:
NJ Web Design